Conno Christou, a seasoned entrepreneur, has always been meticulous about his health, tracking his sleep, biomarkers, and nutrition with precision. However, despite his best efforts, he was diagnosed with an aggressive form of non-Hodgkin's lymphoma. Faced with a daunting treatment regimen, Christou applied his data-driven mindset to navigate the complexities of his care. He gathered multiple opinions from renowned oncologists, ultimately opting for a more aggressive chemotherapy regimen. Throughout his treatment, Christou relied on wearable devices, symptom journals, and AI-powered tools to monitor his progress and identify potential issues. He fed his data into Claude, an AI model that helped him ask informed questions and uncover critical insights. When his final PET scan yielded ambiguous results, Christou used Claude to investigate further, uncovering a potential explanation for the false-positive reading. His experience has given him a newfound perspective on the intersection of healthcare and technology, and he is now more determined than ever to leverage AI to improve patient outcomes. As the founder of Keragon, an AI-powered platform for medical practices, Christou is committed to streamlining administrative tasks and enhancing care. His journey serves as a testament to the potential of AI in healthcare, and he is eager to share his insights with others navigating similar challenges.

Source: TechCrunch